Published in Ann Oncol on January 01, 1993
Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary. Int J Clin Oncol (2015) 1.04
A scoring system for the prognosis and treatment of malignant bowel obstruction. Surgery (2012) 0.89
Management of intestinal obstruction in advanced malignancy. Ann Med Surg (Lond) (2015) 0.81
Management of bowel obstruction in patients with stage IV cancer: predictors of outcome after surgery. Ann Surg Oncol (2012) 0.80
[Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients : a systematic literature review]. Schmerz (2012) 0.78
Palliative percutaneous endoscopic gastrostomy placement for gastrointestinal cancer: Roles, goals, and complications. World J Gastrointest Endosc (2015) 0.75
Conservative treatment of early postoperative small bowel obstruction with obliterative peritonitis. World J Gastroenterol (2013) 0.75
Unusual sized cecal mass presenting without obstruction: a case report. Cases J (2009) 0.75
Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital. Support Care Cancer (2013) 0.75
Colonic stenting as a bridge to surgery for obstructive colorectal cancer: advantages and disadvantages. Surg Today (2016) 0.75
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol (1993) 7.27
Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer (2001) 3.40
Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell (1996) 3.00
Quality-of-life assessment during a palliative care programme. Ann Oncol (1990) 2.67
A new family of mathematical models describing the human growth curve. Ann Hum Biol (1978) 2.34
A validation study of the WHO method for cancer pain relief. Cancer (1987) 2.32
Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol (1998) 2.29
Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol (2001) 2.25
Symptom prevalence and control during cancer patients' last days of life. J Palliat Care (1990) 2.22
Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab (1997) 2.11
Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol (2001) 2.06
Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell (1989) 1.96
Paraplegia following coeliac plexus block. Pain (1993) 1.85
Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. J Pain Symptom Manage (1999) 1.80
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. J Am Coll Cardiol (1989) 1.76
A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int (1994) 1.60
Receptor-mediated phosphorylation of the hepatic insulin receptor: evidence that the Mr 95,000 receptor subunit is its own kinase. Proc Natl Acad Sci U S A (1983) 1.49
Surgical treatment of tuberculous spondylodiscitis. Eur Rev Med Pharmacol Sci (2012) 1.49
Intensity modulated proton therapy: a clinical example. Med Phys (2001) 1.49
Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J Natl Cancer Inst (1999) 1.48
Morphine for relief of cancer pain. Lancet (1996) 1.47
Local toxicity with subcutaneous methadone. Experience of two centers. Pain (1991) 1.43
Visual disturbances in advanced cancer patients: clinical observations. J Pain Symptom Manage (1999) 1.39
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphoma. J Hematother Stem Cell Res (2000) 1.37
Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer (2001) 1.32
Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood (2001) 1.28
Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun (2000) 1.28
Elastofibroma dorsi: 8 case reports and a literature review. J Orthop Traumatol (2008) 1.26
The World Health Organization Cancer Pain and Palliative Care Program. Past, present, and future. J Pain Symptom Manage (1996) 1.25
Bivariate normal values of the bioelectrical impedance vector in adult and elderly populations. Am J Clin Nutr (1995) 1.25
A hybrid approach to EMG pattern analysis for classification of arm movements using statistical and fuzzy techniques. Med Eng Phys (1999) 1.24
Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer (2000) 1.21
WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React (1985) 1.18
EFNS guidelines on cognitive rehabilitation: report of an EFNS task force. Eur J Neurol (2005) 1.17
Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc Natl Acad Sci U S A (1988) 1.16
Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection. Infect Immun (2001) 1.16
Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer (1991) 1.15
Psychological aspects of genital human papillomavirus infection: a preliminary report. J Psychosom Obstet Gynaecol (1993) 1.14
Characterization of a cDNA clone coding for human testis membrane cofactor protein (MCP, CD46). Mol Reprod Dev (1993) 1.13
Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production. J Biol Chem (1994) 1.13
Thrombin and trypsin-induced Ca(2+) mobilization in human T cell lines through interaction with different protease-activated receptors. FASEB J (1996) 1.13
Use of non-steroidal anti-inflammatory drugs in the treatment of pain in cancer. Br J Clin Pharmacol (1980) 1.12
Cancer pain. Postgrad Med J (1984) 1.11
Escherichia coli cytotoxic necrotizing factor-1 (CNF-1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis. J Leukoc Biol (2000) 1.09
Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood (2001) 1.09
Escherichia coli cytotoxic necrotizing factor 1 effaces microvilli and decreases transmigration of polymorphonuclear leukocytes in intestinal T84 epithelial cell monolayers. Infect Immun (1998) 1.09
A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer (1998) 1.08
Characteristics of terminal cancer patients who committed suicide during a home palliative care program. J Pain Symptom Manage (2001) 1.06
Resection of parosteal osteosarcoma of the distal part of the femur: an original reconstruction technique with cement and plate. Sarcoma (2008) 1.05
Sustained polymorphonuclear leukocyte transmigration induces apoptosis in T84 intestinal epithelial cells. J Cell Biol (2000) 1.05
Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage (2000) 1.04
Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol (1996) 1.04
A new international framework for palliative care. Eur J Cancer (2004) 1.04
Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel. J Immunol (1997) 1.01
On withholding nutrition and hydration in the terminally ill: has palliative medicine gone too far? A reply. J Med Ethics (1995) 1.01
Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype. Infect Immun (2001) 1.00
Psychosocial adjustment of patients surgically treated for head and neck cancer. Head Neck (1992) 0.99
Pain measurement in cancer patients: a comparison of six methods. Pain (1994) 0.99
Joubert syndrome with associated corpus callosum agenesis. Eur J Paediatr Neurol (2002) 0.99
Assessing delirium in cancer patients: the Italian versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale. J Pain Symptom Manage (2001) 0.99
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy. J Neurol Sci (1995) 0.98
Antidepressants increase bioavailability of morphine in cancer patients. Lancet (1987) 0.98
Effect of home care on the place of death of advanced cancer patients. Eur J Cancer (1996) 0.98
Receptor cross-linking restores an insulin metabolic effect altered by mutation on tyrosine 1162 and tyrosine 1163. Biochemistry (1989) 0.97
Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. Biochem J (1994) 0.97
Use of an anti-insulin receptor antibody to discriminate between metabolic and mitogenic effects of insulin: correlation with receptor autophosphorylation. EMBO J (1988) 0.97
Sodium naproxen versus sodium diclofenac in cancer pain control. Arzneimittelforschung (1990) 0.95
Insulin and rabbit anti-insulin receptor antibodies stimulate additively the intrinsic receptor kinase activity. EMBO J (1987) 0.95
CD3-stimulated Jurkat T cells mediate IL-1 beta production in monocytic THP-1 cells. Role of LFA-1 molecule and participation of CD69 T cell antigen. Eur Cytokine Netw (1993) 0.95
Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine. Pain (1991) 0.95
The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori (1990) 0.94
Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 3-kinase and Akt activities exert opposing effects on the ERK pathway: importance for the rescue of neuroectodermic cells. J Biol Chem (2001) 0.94
Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomised, double-blind clinical trial. Br Homeopath J (2000) 0.94
Indoprofen, a new analgesic and anti-inflammatory drug in cancer pain. Clin Pharmacol Ther (1975) 0.94
Characterization of ouabain-resistant mutants of a canine kidney cell line, MDCK. J Biol Chem (1983) 0.94
Effect of Helicobacter pylori on polymorphonuclear leukocyte migration across polarized T84 epithelial cell monolayers: role of vacuolating toxin VacA and cag pathogenicity island. Infect Immun (2000) 0.94
Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine. Acta Paediatr (1992) 0.93
Pseudosubstrates of the sarcoplasmic Ca2+-ATPase as tools to study the coupling between substrate hydrolysis and Ca2+ transport. J Biol Chem (1979) 0.93
Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care. Nutrition (1996) 0.92
(Na+, K+)-activated adenosinetriphosphatase of axonal membranes, cooperativity and control. Steady-state analysis. Eur J Biochem (1976) 0.92
Ultrasonography of arm edema after axillary dissection for breast cancer: a preliminary study. Lymphology (2001) 0.92
Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction. Oncogene (1998) 0.92
Skeletal muscle and nutritional assessment in chronic renal failure patients on a protein-restricted diet. J Intern Med (2004) 0.92
Palliative care research. Eur J Cancer (2001) 0.91
Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Ann Oncol (1998) 0.91
Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage (1991) 0.91
Epidemiological and clinical features of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci (2012) 0.91
Dyspnea: pathophysiology and assessment. J Pain Symptom Manage (1997) 0.90
Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoa. J Immunol (1993) 0.90
Suicide among patients with cancer cared for at home by palliative-care teams. Lancet (1999) 0.89
The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. Oncogene (1997) 0.89